The IPKat

DECEMBER 5, 2022

Whilst a bit different from PatKat's stable Katfood of EPO case law, the recent decision from the Court of Appeal in G W Pharma v Otsuka ( [2022] EWCA Civ 1462 ) is nonetheless food for thought. Case background The defendant in the case in question was GW Pharma, a UK based pharma company focused on cannabis derived medicines.

Patent 67

Patent Contracts Government Law 67

SpicyIP

DECEMBER 5, 2022

Sun Pharma Laboratories Ltd vs Intas Pharmaceuticals Limited & Anr. Levi Straus & Company vs. Sunil Yadav on 24 November, 2022 (Delhi District Court). Bennett, Coleman And Company Ltd. Levi Straus & Company vs Sh. The subscription/ distribution revenue received by the assessee here was not royalty.

Trademark 105

Trademark Registering Trademarks Registration IP 105

SpicyIP

JULY 7, 2021

Aside from the licensing agreement with Natco, Eli Lilly went on to sign more licensing deals with several Indian firms such as Cipla, Sun Pharma, and Lupin among others to manufacture the drug locally on a non-exclusive, royalty-free basis.

Licensing 122

Licensing Government Reporting Patent 122

SpicyIP

JULY 11, 2021

While Bajaj claims that it can manufacture the expensive drug at a much cheaper price, I noted that Natco pharma, which had formerly applied for a CL as well but had withdrawn after concluding a voluntary license with Eli Lilly, was already selling Baricitinib at Bajaj’s proposed prices. Delhi High Court in FMC Corporation & Anr.

Moral Rights 105

Moral Rights Journalism Licensing IP 105

SpicyIP

MAY 15, 2023

Agreement on Royalty Sharing Signed between ISRA and Music Labels! Image from here Recently, ISRA entered into a royalty-sharing agreement with Indian music labels. This comes only a few days after the Bombay High Court’s order recognizing the royalty rights of lyrics and musical composers.

Trademark 104

Trademark Registration Cease and Desist IP 104

SpicyIP

JULY 10, 2023

For instance, the Delhi High Court directed Oppo to deposit the royalty amount, in its high-profile SEP litigation with Nokia. Natco Pharma on 05 July, 2023 (Delhi High Court) Image from here The dispute pertained to an interim injunction application against the infringement of the plaintiff’s ‘Regorafenib’ specie patent.

Registration 98

Registration Copyright Infringement Trademark Copyright 98

SpicyIP

DECEMBER 30, 2023

The judgement was passed in a writ petition filed by Natco Pharma against the Controller’s order granting Novartis a patent for a form of the Valsartan-Sacubitril complex, after conducting a unilateral hearing excluding Natco therefrom. Controller of Patents and Designs and Raytheon Company v. In another judgement, Raytheon Company v.

IP 124

IP Copyright Trademark Intellectual Property 124

Bio Law Blog

FEBRUARY 18, 2020

As companies continue to develop this new and promising therapy, patent litigation inevitably follows. Researchers and the medical community clearly see CAR T-Cell therapy as a new frontier for cancer treatment, and big pharma has jumped in. CAR T-Cell therapy, a new biologic therapy, is taking off. DLBCL is the most common NHL.

Litigation 40

Litigation Patent Licensing Patent Infringement 40

SpicyIP

SEPTEMBER 11, 2023

On 05 September, 2023 (Delhi High Court) In an appeal against the single judge order, the division bench of the Delhi High Court restrained Bhojpuri artist Khesari Lal Yadav from engaging with other music companies except the appellant for monetizing any new songs till September 30, 2023. Dr. Reddy’s Labs Ltd. Triller Inc.

Registration 105

Registration Trademark Copyright Music 105

SpicyIP

JANUARY 2, 2022

The Supreme Court held that such payments are not ‘royalty’ and recognised the doctrine of exhaustion in software. The second suit was filed by IPRS and PPL against an event management company for broadcasting music without authorization. Narayani Trading Company [Bombay High Court]. Sanjay Soya Private Limited v.

IP 143

IP Intellectual Property Copyright Trademark 143

SpicyIP

MAY 8, 2022

For instance, Pharma companies often claim ( and often get! ) Why should they be granted state-backed privileges just because they were given tools (knowledge) that others were denied, and then able to make something with it? .

IP 98

IP Invention Inventor Music 98

SpicyIP

JANUARY 27, 2024

The Pharma industry approached the court. But the Delhi High Court refuses to allow the pharma industry’s plea seeking a stay on the NPPA price cap decision. If you need more here, Balaji Subramanian’s three-part post on Pharma Price Control and Policy Schizophrenia is your next stop (here’s Part II and Part III ).

IP 64

IP Licensing Copyright Blogging 64